As of November 2024, Akebia Therapeutics has a market cap of $257.15M. This makes Akebia Therapeutics the world's 15702th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $276.95M | 18.56% |
2023 | $233.60M | 114.90% |
2022 | $108.70M | -74.47% |
2021 | $425.76M | -19.29% |
2020 | $527.49M | -55.70% |
2019 | $1.19B | 14.29% |
2018 | $1.04B | -62.81% |
2017 | $2.80B | 42.84% |
2016 | $1.96B | -19.43% |
2015 | $2.43B | 11.00% |
2014 | $2.19B | - |